Shabahang Shahrokh 4
4 · Aditx Therapeutics, Inc. · Filed Mar 22, 2021
Insider Transaction Report
Form 4
Shabahang Shahrokh
DirectorCHIEF INNOVATION OFFICER
Transactions
- Exercise Out-of-Money
Common Stock
2021-03-17$4.00/sh+18,750$75,000→ 1,015,006 total(indirect: See Footnote) - Exercise Out-of-Money
Warrant (Right to Buy)
2021-03-17−18,750→ 0 total(indirect: See Footnote)Exercise: $4.00From: 2018-03-17Exp: 2021-03-17→ Common Stock (18,750 underlying)
Footnotes (2)
- [F1]967,784 shares of common stock are owned beneficially by the Shabahang-Hatami Family Trust, Shahrokh Shabahang, Trustee.
- [F2]Held beneficially by the Shabahang-Hatami Family Trust, Shahrokh Shabahang, Trustee.